Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page
CDSCO Panel Approves Sun Pharma’s Phase IV Clinical Trial for Dual Release Pantoprazole in Treating Gastroesophageal Reflux Disease (GERD)

CDSCO Panel Approves Sun Pharma’s Phase IV Clinical Trial for Dual Release Pantoprazole in Treating Gastroesophageal Reflux Disease (GERD)

by Team Small News | Aug 12, 2025 | Pharma, Sun Pharma

Sun Pharma, a leading pharmaceutical company, has announced that its Phase IV study on dual release pantoprazole for the treatment of Gastroesophageal Reflux Disease (GERD) has received acceptance from the Central Drugs Standard Control Organization (CDSCO) panel....
CDSCO Panel Approves Sun Pharma’s Phase IV Clinical Trial for Dual Release Pantoprazole in Treating Gastroesophageal Reflux Disease (GERD)

Volini by Sun Pharma Introduces ‘Uparna’, a Groundbreaking Initiative for Devotees Traveling to Pandharpur

by Team Small News | Aug 11, 2025 | Pharma, Sun Pharma

Sun Pharmaceutical Industries Limited, India’s leading pharmaceutical company, has launched a unique initiative through its pain relief brand, Volini. During the annual Pandharpur Wari pilgrimage in Maharashtra, one of the oldest and most significant spiritual...

Fortis acquires Shrimann hospital in a massive Rs 462 crore deal

by Team Small News | Aug 10, 2025 | Fortis, Pharma

Fortis Healthcare has expanded its presence in Punjab by acquiring the 228-bed Shrimann Superspecialty Hospital for a consideration of Rs 462 crore. This marks the fifth hospital of Fortis in Punjab, with existing hospitals in Ludhiana, Mohali, and Amritsar. The...

Biocon Ltd (BOM:532523) Reports Strong Revenue Increase in Q1 2026 Earnings, Despite Margin Pressures, as Noted by GuruFocus on Investing.com Canada.

by Team Small News | Aug 10, 2025 | Biocon, Pharma

Biocon Ltd, an Indian biopharmaceutical company, reported its Q1 2026 earnings, showcasing strong revenue growth despite margin pressures. Here are the highlights from the earnings call: Revenue Growth: Biocon Ltd posted a robust revenue growth of 23% year-over-year...
ZDS-Varenicline, a smoking cessation medication developed by Zydus Lifesciences, receives approval from Health Canada, as reported by geneonline.com.

ZDS-Varenicline, a smoking cessation medication developed by Zydus Lifesciences, receives approval from Health Canada, as reported by geneonline.com.

by Team Small News | Aug 9, 2025 | Pfizer, Pharma, Zydus

Zydus Lifesciences, a leading pharmaceutical company, has received approval from Health Canada for its smoking cessation drug, ZDS-Varenicline. This approval marks a significant milestone for the company, as it expands its presence in the Canadian market....
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress